Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Greenwich LifeSciences, Inc. (GLSI) had Operating Cash Flow per Share of $-0.30 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-4.03M |
|
-- |
|
-- |
|
$4.05M |
|
$-4.05M |
|
$0.02M |
|
$-4.03M |
|
$-4.03M |
|
$-4.03M |
|
$-4.03M |
|
$-4.03M |
|
$-4.03M |
|
$-4.05M |
|
$-4.05M |
|
13.37M |
|
13.37M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$3.13M |
|
-- |
|
-- |
|
$3.13M |
|
$1.69M |
|
-- |
|
-- |
|
$1.69M |
|
$1.44M |
|
$1.44M |
|
$1.44M |
|
13.47M |
|
| Cash Flow Statement Financials | |
$-4.07M |
|
-- |
|
$3.10M |
|
$4.09M |
|
$3.13M |
|
$-0.97M |
|
$3.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-279.63% |
|
-279.63% |
|
-128.80% |
|
-279.63% |
|
$0.11 |
|
$-0.30 |
|
|
Operating Cash Flow per Share |
$-0.30 |